top of page


Cannabidiol (CBD) in Cancer Management

Combination therapy with cannabidiol and chemotherapeutics in canine urothelial carcinoma cells

The ECS - A target for cancer treatment

Circulating Endocannabinoids in Canine Multicentric Lymphoma Patients

Abstract - Anti-proliferative effect of cannabidiol (CBD) against B and-T-cell lymphoma

The effect of cannabidiol on canine neoplastic cell proliferation and mitogen-activated protein kinase activation during autophagy and apoptosis

Suppression of vascular endothelial growth factor expression by cannabinoids in a canine osteosarcoma cell line​

The heterogeneity and complexity of Cannabis extracts as antitumour agents

Cannabidiol Induces Apoptosis and Perturbs Mitochondrial Function in both Human and Canine Glioma Cells

CP55,940 increases intracellular Ca2+ levels in Madin-Darby canine kidney cells

Novel effect of CP55,940, a CB1/CB2 cannabinoid receptor agonist, on intracellular free Ca2+ levels in bladder cancer cells

Cannabis Therapeutics and the Future of Neurology


GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine | Oncogene


Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients

Cannabis sativa: The Plant of the Thousand and One Molecules | Plant Science


Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation. - PubMed - NCBI


Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells


Rates of cannabis use in patients with cancer


Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression


Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene, isocaryophyllene and paclitaxel


Integrating cannabis into clinical cancer care


Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol


Endocannabinoids and Cancer


Studies on CBD and Cancer


Cannabis and Cannabinoids (PDQ®)—Health Professional Version - National Cancer Institute


Practical considerations in medical cannabis administration and dosing

bottom of page